Hoechst and Rhône-Poulenc Rorer were the two companies that merged to form Aventis. Despite Sanofi-Synthélabo’s size, the company found itself forced to partner with larger pharmaceutical ...

Sanofi India Limited, (Previously known as Aventis Pharma Limited) was incorporated in May, 1956. The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11 ...

Now, some of them are looking for alternatives as geopolitical tensions rise. From big pharmaceutical companies such as AstraZeneca to small biotechnology firms like Amicus Therapeutics of New ...

Jazz Pharmaceuticals has reported third-quarter revenue of $1 billion, a 9% increase over the prior year, fueled by strong ...

US-based investment firm takes controlling stake in Opella, while France's government moves to ensure the company remains in ...

Research results featured heavily in the news last week, first with Viking Therapeutics releasing promising early-stage data ...

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

It is generally well appreciated that the pharmaceutical industry has entered ... Bristol–Myers Squibb/Sanofi–Aventis), valsartan (Diovan; Novartis) and topiramate (Topamax; Johnson & Johnson ...

The global pharmaceutical industry is growing and offers an attractive opportunity for investors. Well-established pharmaceutical stocks include AbbVie, Eli Lilly, Johnson & Johnson, and Pfizer.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

The focal points of the events were artificial intelligence and global market developments and innovations for air cargo and ...

Danish biotechnology company Zealand Pharma said on Thursday it expected to initiate a so-called Phase 2b trial with its obesity treatment candidate petrelintide in the fourth quarter of 2024.